Authors

Latest:

Anticipating Key Studies and Pipeline Treatments in mCRC Landscape

The experts provide their final thoughts surrounding the impact of prospective trials and therapy regimens for treating patients with refractory mCRC.

Scott Rowley, MD

Latest:

Dr. Scott Rowley on Allogeneic Stem Cell Transplant

Scott Rowley, MD, the Chief of John Theurer Cancer Center's Blood and Marrow Stem Cell Transplantation Division, discusses the challenges of allogeneic stem cell transplant.

Scott Samuelson, MD

Latest:

Dr. Samuelson on the Comorbidities that Affect Treatment Decisions in Prostate Cancer

Scott Samuelson, MD, medical oncologist at Utah Cancer Specialists, discusses the comorbidities that may affect treatment decisions for patients with metastatic prostate cancer.

Scott T. Tagawa, MD

Scott T. Tagawa, MD, MS, FACP, FASCO, is a professor of medicine and urology at Weill Cornell Medicine and an attending physician at NewYork-Presbyterian – Weill Cornell Medical Center in New York.

Latest:

PSMA Theranostics, ctDNA Testing, and Combination Regimens in GU Oncology Spark Conversation at CFS: With Benjamin P. Levy, MD; Scott T. Tagawa, MD, MS, FACP, FASCO

Drs Levy and Tagawa discuss the rapidly evolving treatment paradigms for prostate cancer and RCC live at the 43rd Annual Chemotherapy Foundation Symposium.

Scott T. Tagawa, MD, MS

Latest:

Results of the VISION Trial and Real-World Use of 177Lu-PSMA-617 in mCRPC

Reflections on results of the VISION trial, which utilized 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer.

Se Ik Kim, MD

Latest:

Dr. Kim Discusses Minimally Invasive Surgery and Laparotomic Surgery in Cervical Cancer

Se Ik Kim, MD, research fellow, Department of Obstetrics and Gynecology, Seoul National University Hospital, discusses the use of minimally invasive surgery and laparotomic surgery in patients with cervical cancer.

Sean Benson

Latest:

Automating the Documentation and Coding Process

Accurate documentation and coding is essential for efficient billing and reimbursement.

Sean C. Dowdy, MD

Latest:

Dr. Dowdy on the Association of Molecular Subtypes and Responses to Bevacizumab in Ovarian Cancer

Sean C. Dowdy, MD, discusses the association of molecular subtypes and responses to bevacizumab in ovarian cancer.

Sean Dowdy, MD

Latest:

Ovarian Cancer Subtypes May Predict Response to Bevacizumab

Sean Dowdy, MD, a Mayo Clinic gynecologic oncologist discusses a study showing molecular sequencing could identify ovarian cancer patients who are most likely to benefit from treatment with bevacizumab (Avastin), a Mayo Clinic-led study has found.

Sean Grimm, MD

Latest:

Dr. Grimm on the Brain Cancer Predictive Marker MGMT

Dr. Sean Grimm from Northwestern University, Feinberg School of Medicine on MGMT as a Predictive Marker in Brain Cancer

Sean Johnson

Latest:

Coping With Burnout? Tips on Handling This Occupational Hazard

Burnout is described as a syndrome of "emotional exhaustion, depersonalization, and feelings of low personal accomplishment," and is an increasingly problematic condition among physicians for a multitude of reasons.

Sean Szeja, MD

Latest:

Dr. Szeja on Adjuvant Radiation Therapy After Lumpectomy in Elderly Patients With TNBC

Sean Szeja, MD, radiation oncologist, University of Texas Medical Branch, discusses outcomes associated with adjuvant radiation therapy following lumpectomy for elderly patients with triple-negative breast cancer.

Sean Truong, MD

Latest:

Different Faces of a Career in Oncology

At various stages of our lives, most of us experience situations or events that help us to mature and may lead to decisions that affect our futures. Two such events in my life forged my career choice as a communitybased oncologist.

Seema Harichand-Herdt, MD

Latest:

Adjuvant Therapy for Non-Small Cell Lung Cancer: Impact of Recent Clinical Trials on Community Practice

Non-small cell lung cancer (NSCLC) is diagnosed at an early stage, when it is amenable to surgical resection in approximately 20% to 25% of cases.

Selena Juarez Stuart, MD

Latest:

Dr. Stuart on Risks of Phase I Liver Dysfunction Studies

Selena Juarez Stuart, MD, hematology/oncology fellow, Cancer Therapy & Research Center, The University of Texas Health Science Center at San Antonio, discusses the risks and benefits of phase I liver dysfunction studies.

Selina Chen-Kiang, PhD

Latest:

Challenges in the Treatment of Patients With MCL

Selina Chen-Kiang, PhD, professor of pathology and immunology, Weill Cornell Medicine, discusses challenges in the treatment of patients with mantle cell lymphoma (MCL).

Sergio A. Giralt, MD

Latest:

Dr Giralt on Determining Transplant Eligibility in MDS

Sergio A. Giralt, MD, discusses how to determine transplant eligibility and the evolving role of transplant for patients with myelodysplastic syndromes.

Sergio A. Giralt, MD, Memorial Sloan Kettering Cancer Center

Sergio Giralt, MD

Latest:

VOD: Ensuring Best Outcomes

Experts share tips for treating patients with VOD with defibrotide, including strategies to ensure best possible outcomes.

Sergio Lavilla-Alonso PhD

Latest:

Phase II Clinical Trial of Intratumoral Dendritic Cells Injections and Neoadjuvant Radiotherapy in Resectable Soft Tissue Sarcomas

Neoadjuvant radiation with dendritic cell injections has the potential to be safe, effective, and immunogenic in high-grade soft tissue sarcoma and needs to be confirmed in randomized larger clinical trials.